BlackRock’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,000
Closed -$2.69M 5834
2021
Q3
$2.69M Buy
+7,000
New +$2.58M ﹤0.01% 4189

Other funds holding MRNA

BlackRock's MRNA Position: Q2 2026 in Review

BlackRock increased its Moderna (MRNA) stake by 3.3% in Q2 2026, buying an estimated $49.9M and bringing the position to 30,599,409 shares worth $2.14B. The position accounts for 0.03% of the portfolio, ranked #427.

BlackRock first reported a position in MRNA in Q4 2018 and has held it in 31 quarters since. The position peaked at $10.3B in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • BlackRock held 30,599,409 shares of Moderna worth $2.14B as of Q2 2026.
  • BlackRock bought 963,533 Moderna shares in Q2 2026, an estimated $49.9M.
  • Moderna made up 0.03% of BlackRock's portfolio in Q2 2026, its #427 holding.
  • BlackRock first reported a position in Moderna in Q4 2018 and has held it in 31 quarters since.
  • BlackRock's Moderna position peaked at $10.3B in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.